Acute Dose-Dependent Neuroprotective Effects of Poly(pro-17β-estradiol) in a Mouse Model of Spinal Contusion Injury
Overview
Authors
Affiliations
17β-Estradiol (E2) confers neuroprotection in preclinical models of spinal cord injury when administered systemically. The goal of this study was to apply E2 locally to the injured spinal cord for a sustained duration using poly(pro-E2) film biomaterials. Following contusive spinal cord injury in adult male mice, poly(pro-E2) films were implanted subdurally and neuroprotection was assessed using immunohistochemistry 7 days after injury and implantation. In these studies, poly(pro-E2) films modestly improved neuroprotection without affecting the inflammatory response when compared to the injured controls. To increase the E2 dose released, bolus-releasing poly(pro-E2) films were fabricated by incorporating unbound E2 into the poly(pro-E2) films. However, compared to the injured controls, bolus-releasing poly(pro-E2) films did not significantly enhance neuroprotection or limit inflammation at either 7 or 21 days post-injury. Future work will focus on developing poly(pro-E2) biomaterials capable of more precisely releasing therapeutic doses of E2.
Funnell J, Fougere J, Zahn D, Dutz S, Gilbert R Adv Biol (Weinh). 2024; 8(10):e2300531.
PMID: 38935534 PMC: 11473240. DOI: 10.1002/adbi.202300531.
Advances in molecular therapies for targeting pathophysiology in spinal cord injury.
Kim H, McCrea M, Li S Expert Opin Ther Targets. 2023; 27(3):171-187.
PMID: 37017093 PMC: 10148912. DOI: 10.1080/14728222.2023.2194532.